6Yoo BC, Kim HJ, Do JH, Park SM. Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B. Taehan Kan Hakhoe Chi 2002;8:381-388.
7Gunther S, von Breunig F, Santantonio T, Jung MC, Gaeta GB,Fischer L, Sterneck M, Will H. Absence of mutations in the YMDD motif/B region of the hepatitis B virus polymerase in famciclovir therapy failure. J Hepatol 1999;30:749-754.
8De Clercq E. Antiviral drugs in current clinical use. J Clin Virol 2004;30:115-133.
9Humphries JC, Dixon JS. Antivirals for the treatment of chronic hepatitis B: current and future options. Intervirology 2003;46:413-420.
10Stuyver LJ, Locarnini SA, Lok A, Richman DD, Carman WF,Dienstag JL, Schinazi RF. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001;33:751-757.
